Skip to main content
. 2021 Sep 15;13(9):1476. doi: 10.3390/pharmaceutics13091476

Figure 4.

Figure 4

(A) IMQ retention (mean ± SD, n ≥ 4) in the epidermis and dermis, red dots (Inline graphic) represent IMQ concentration in the formulations applied. Data on Transcutol® saturated solution is from [15]. (B) Delivery efficiency (% delivered after 5 h) of TO20 and semisolid formulations. (p * < 0.05); p-values obtained from t-test analysis for epidermis, dermis and total amount of the drug in the skin for all formulations tested are reported in Table S4.